Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-06-21
2005-06-21
Huang, Evelyn Mei (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S214030, C546S063000, C546S072000, C544S171000
Reexamination Certificate
active
06908927
ABSTRACT:
The invention relates to pyridopyranoazepine derivatives, to pharmaceutical compositions containing them, to process for preparing them, and to the method of use thereof in the treatment or prevention of disorders associated with a dysfunction of the nicotine receptors.
REFERENCES:
patent: 6143761 (2000-11-01), Lochead et al.
patent: 2761072 (1998-09-01), None
patent: WO 97/11072 (1997-03-01), None
Nordvall et al., J. Medicinal Chemistry, vol. 39, No. 17, pp. 3269-3277, (1996).
Derwent Patent Abstract No. 199844 (2001).
Gopalakrishnan et al., European Journal of Pharmacology, 290 (1995), 237-246.
Levin, ED, Simon BB, Psychopharmacology (Berl) Aug. 1998:138(3-4):217-30.
Galli Frederic
Jegham Samir
Lochead Alistair
Samson Axelle
Alexander Michael D.
Huang Evelyn Mei
Sanofi-Synthelabo
LandOfFree
Pyridopyranoazepine derivatives, their preparation and their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridopyranoazepine derivatives, their preparation and their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridopyranoazepine derivatives, their preparation and their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3517765